Emergen Research presents an in-depth analysis of the Global New York Cannabis Market, offering a detailed understanding of industry trends, growth patterns, and future opportunities. By considering historical data from earlier years and using 2019 as the base year, the study delivers a clear and structured outlook of how the New York Cannabis market is expected to evolve.
The research content has been designed to assist investors, stakeholders, and business strategists in making informed decisions. It provides strategic recommendations that enable organizations to maximize returns on their investments while identifying new avenues for growth. The study carefully evaluates both established players and emerging participants in the market, helping businesses understand the competitive positioning and future potential of different companies.
The New York Cannabis market is expected to grow from an estimated USD 561.5 million in 2024 to USD 2342.6 million in 2033, at a CAGR of 17.20%.
To satisfy the demands of the "mainstream" marijuana user, sativa consumer product manufacturers and sellers are changing quickly. Customers can now choose from a wider range of items, such as topicals, concentrates, and infused products, rather than just smoking flowers via joints, pipes, or bongs. Consumers turned to freshly created alternatives like edibles and other infused items as a result of COVID-19-related worries.
Compared to consuming an edible substance, inhaling the product causes THC to enter the lungs and bloodstream swiftly, resulting in the user experiencing the related mind-altering effects much faster. The disadvantages of edibles, like the erratic effects of marijuana after intake, are starting to be addressed by advances in scientific research and commercial innovation. Topical or sublingual products that are intended to be absorbed through the skin or under the tongue are examples of more recent types of infusion products.
In the market, hemp-based delicacies, including candies, chocolates, and drinks, are still very popular. Such delicacies produce a euphoric "high" that lasts longer than that produced by breathing smoke or vapour, but it takes one to two hours to start. However, product innovation and packaging-related changes are anticipated to be crucial in improving edibles sales sentiments.
They are anticipated to expand at the quickest rate throughout the forecast year. For example, the Office of Cannabis Management stated that there were 161 adult-use dispensaries in the state in 2023, while the New York State Supreme Court approved the opening of 23 cannabis stores in the same year. Retailers and manufacturers must adjust to shifting consumer preferences and legal requirements as the market develops in order to stay competitive.
A key feature of the report is its ability to address critical business questions that directly impact market strategies. It explores which segments are expected to demonstrate strong growth, how consumer demand is likely to shift, and what macroeconomic and microeconomic factors are influencing the market. Additionally, it provides insights into the role of technological advancements and research and development activities in shaping the future of the New York Cannabis market.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-free-sample/4902
The report also includes a detailed evaluation of market drivers and influencing factors. These elements play a crucial role in determining the pace of growth and the overall direction of the market. By examining trends such as innovation, changing consumer preferences, and evolving industry standards, the study provides a comprehensive understanding of what is driving the New York Cannabis market forward.
- Flowers
- Oils and Tinctures
- Hemp
- Marijuana
- Medical
- Recreational
- Industrial
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Benelux
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East and Africa
- Saudi Arabia
- UAE
- South Africa
- Turkey
- Rest of MEA
- United States
- Canada
- Mexico
- Germany
- France
- United Kingdom
- Italy
- Spain
- Benelux
- Rest of Europe
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Brazil
- Rest of Latin America
- Saudi Arabia
- UAE
- South Africa
- Turkey
- Rest of MEA
Key Questions the Report Will Answer
- What was the market size of the New York Cannabis market in 2024?
- The New York Cannabis market size in 2024 was USD 561.5 million.
- What is the expected revenue Compound Annual Growth Rate (CAGR) of the New York Cannabis market over the forecast period?
- The New York Cannabis market is expected to register a revenue Compound Annual Growth Rate (CAGR) of 17.20% over the forecast period.
- Which factors are expected to drive New York Cannabis market revenue growth?
- Regulatory and Policy Relaxation is a growing market are expected to drive revenue growth of the global New York Cannabis market.
- Which regional market is expected to account for the largest revenue share in the New York Cannabis market?
- The Asia Pacific market is expected to account for the largest revenue share in the New York Cannabis market over the forecast period.
- Which are some of the major companies included in the global New York Cannabis market report?
- Some of the major companies in the global New York Cannabis market include Etain, Acreage Holdings, The Cannabist Company, Cresco Labs Inc., Curaleaf, Hemp Farms of New York, iAnthus Capital Holdings, Inc., PharmaCann Inc., VIREO HEALTH INTERNATIONAL, INC., NOWAVE
- The New York Cannabis market size in 2024 was USD 561.5 million.
- The New York Cannabis market is expected to register a revenue Compound Annual Growth Rate (CAGR) of 17.20% over the forecast period.
- Regulatory and Policy Relaxation is a growing market are expected to drive revenue growth of the global New York Cannabis market.
- The Asia Pacific market is expected to account for the largest revenue share in the New York Cannabis market over the forecast period.
Another important aspect covered in the research is the impact of the COVID-19 pandemic. The report assesses how global disruptions, including lockdowns and supply chain challenges, have affected market performance. It also provides insights into how businesses have adapted to these changes and outlines the expected recovery trajectory. This analysis helps organizations prepare for uncertainties and develop strategies that ensure long-term resilience.
Competitive Landscape:
The competitive landscape forms a central part of the report, offering valuable insights into the strategies adopted by leading market players. The study provides an overview of key companies operating in the New York Cannabis market, highlighting their business models, product portfolios, and recent developments. It also examines activities such as mergers, acquisitions, collaborations, and technological innovations that have influenced the competitive environment.
The coronavirus outbreak presented opportunities to assist the sector and loosen rules. For example, in June 2021, the Cannabis Regulation Act (CRA) established a thorough licensing, taxing, and regulatory enforcement framework for cannabis use by adults in New Mexico and the United States. The Cannabis Control Division (CCD) would administer the statute. The act allows adults 21 years of age and older to possess up to 6 mature plants, 2 ounces of flour, 800 mg of infused consumables, and 16 grams of extract.
Nonetheless, a rising number of governments have established legal frameworks for adults to use marijuana for social, religious, and cultural purposes in addition to medical ones. Additionally, formalising the production, trade, and cultivation of the product in a (legally regulated) legal marijuana market will make it easier for consumers to obtain information and increase their consumption, which is anticipated to create opportunities for the market in the years to come.
- Regulatory and Policy Relaxation is a growing market.
To provide a deeper understanding of market competition, the report utilizes advanced analytical tools such as Porter’s Five Forces Analysis, SWOT analysis, feasibility analysis, and investment return analysis. These tools help evaluate the strengths, weaknesses, opportunities, and threats faced by companies, allowing businesses to identify areas for improvement and growth.
Custom Requirements can be requested for this Report [Customization Available] @ https://www.emergenresearch.com/request-for-customization/4902
Market Segmentation:
The report further explores the segmentation of the New York Cannabis market, offering insights into how different categories contribute to overall growth. By analyzing the market based on types and applications, the study provides a clear understanding of demand patterns and consumption behavior. This segmentation enables businesses to focus on high-growth areas and optimize their strategies accordingly.
The market for cannabis in New York has been expanding quickly since it was made legal for recreational use by adults in 2021. The state's sizable population and flourishing tourism industry make it a huge opportunity. Cultivation, processing, sale, and ancillary services are all included in the market, which emphasises equity-driven licensing to help marginalised populations.
Established multi-state operators (MSOs) such as Curaleaf and Cresco Labs, as well as up-and-coming regional companies, are important participants. Strict regulatory frameworks, consumer preferences for high-end and organic products, and growing competitiveness all influence the competitive landscape. As the market develops in this profitable condition, innovations in product offerings and branding become increasingly important.
In August 2024, Curaleaf announced the appointment of Executive Chairman Boris Jordan as Chairman and CEO in place of departing CEO Matt Darin, who will retire but continue to serve as a special adviser until the end of the year.
- Etain
- Acreage Holdings
- The Cannabist Company
- Cresco Labs Inc.
- Curaleaf
- Hemp Farms of New York
- iAnthus Capital Holdings, Inc.
- PharmaCann Inc.
- VIREO HEALTH INTERNATIONAL, INC.
- NOWAVE
In addition to segmentation, the report presents a detailed overview of market dynamics, including supply-demand balance, production levels, and pricing trends. These factors are essential for understanding how the market operates and for making informed decisions regarding resource allocation and strategic planning.
The research also includes a structured overview of the report content, guiding readers through various aspects of the market. It covers key areas such as market overview, global analysis, segmentation insights, revenue evaluation, competitive landscape, market share analysis, and factors influencing growth. This organized approach ensures that users can easily navigate the report and extract relevant information.
Another strength of the New York Cannabis market research content is its focus on providing actionable recommendations. The report offers guidance on strategic planning, market entry, and expansion opportunities, helping businesses strengthen their position in the industry. These insights are particularly useful for new entrants as well as established players seeking to expand their operations.
Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/new-york-cannabis-market
Emergen Research ensures that its content remains relevant by continuously updating its findings to reflect the latest market developments. This commitment to accuracy and timeliness makes the report a reliable resource for businesses operating in dynamic environments.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: https://www.emergenresearch.com/
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com